PROM1 and ovarian carcinoma: On this basis, we conclude that the existence of CD133 cellular expression and localization in various groups of ovarian tumours of serous epithelial origin, ranging from benign, borderline, and malignant entities, indicates the involvement of these markers in ovarian cancer tumorigenesis.